You searched for "quality"

1666 results found

Heidelberg Engineering Welcomes Nick Capewell to the Clinical Sales Team

We’re delighted to welcome Nick Capewell to the clinical sales team at Heidelberg Engineering. Nick Capewell. Nick joins us after more than 10 years at University Hospitals Birmingham, where he trained and worked as an Ophthalmic Science Practitioner. Most recently,...

Artificial intelligence and oculomics: Improving global health

The application of artificial intelligence (AI), and in particular deep learning, to high-resolution ocular imaging has led to many new discoveries, enabling the prediction of multiple different systemic diseases from ocular biomarkers. This emerging field is known as ‘oculomics’ [1]....

ANZGS Congress 2026

"As Chair of the Australian and New Zealand Glaucoma Society I am pleased to invite you to the 2026 ANZGS Congress which will be held in Sydney from 13 – 15 February 2026. The 2025 ANZGS Congress was held in...

Canadian centre experience with ocular cystinosis cases

Ocular cystinosis (OC) is an uncommon recessive genetic disease occurring in about one case per 100–200,000 live births. Patients have accumulation of cystine crystals within tissues. Ocular symptoms include photophobia, blepharospasm, foreign body sensation, retinopathy and visual impairment. Crystals have...

Kilt Walk Veteran says thank you to charity for life changing support

A veteran has led his ‘Daredevils’ team on a 22.7 mile walk to say thank-you to Sight Scotland Veterans for all the life changing support they provide.

Glaucoma UK announces the recipients of its 2025 project grants

Glaucoma UK is delighted to announce the three recipients of our 2025 project grants. The panel had a difficult time deciding between some strong applications. The recipients are: Associate Professor Kuang Hu, at UCL Institute of Ophthalmology. His project is...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Wearing glasses boosts income by a third in low-income communities, finds landmark new study

A pair of reading glasses increases the earnings of people in low-income communities by 33% according to new research.

In conversation with Prof Carrie MacEwen, Chair of The Way Forward and President, The Royal College of Ophthalmologists

Prof Carrie MacEwen. Scope for optimising capacity within the Hospital Eye Service (HES)? The demand for ophthalmic care continues to grow with no increase in capacity. In order to be able to continue to deliver adequate care ophthalmologists have devised...

In conversation with Imran Rahman (CHEC)

Imran Rahman, CEO and Consultant Ophthalmologist, CHEC, spoke to Chris Henson about tackling the COVID-19 backlog, community-based support for the NHS, and the digitisation of healthcare. Without major intervention, will we ever see an end to the COVID-19-induced NHS backlog,...

In conversation with Marc Labetoulle

Following the hugely successful 10th Tear Film & Ocular Surface Society (TFOS) 2024 Conference which took place in Venice, Italy between 30 October – 2 November, we managed to have a quick Q&A with presenting attendee, Marc Labetoulle. Delivering his...

GDPR, email and private practice

A new set of data protection regulations became law in the EU (including the UK) in May 2018. General Data Protection Regulation (GDPR) replaces the 1988 Data Protection Act. The regulation brings new rights and expectations about how our personal...